CompletedNot Applicable

Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection

South Korea138 participantsStarted 2022-06-09

Plain-language summary

During endoscopy, the patient is sedated to relieve pain and improve the ease of the procedure. Sedation endoscopy using propofol is effective, but has the disadvantage that cardiopulmonary side effects are frequently observed. However, etomidate is known to have hemodynamic and respiratory stability.The purpose of this study was to compare the efficacy and safety of etomidate and propofol in sedated gastric endoscopic submucosal dissection.

Who can participate

Age range19 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 19-80 * American Society of Anesthesiologists Physical Status Classification System (ASA) score of I, II, III * Scheduled endoscopy Exclusion Criteria: * Pregnancy * Previous study History of hypersensitivity to drugs or substances containing soy or egg ingredients * Those who think that tracheal intubation will be difficult * Obstructive sleep apnea * History of side effects from previous sedatives * People with severe liver disease, kidney disease, or heart disease * Those who want a non-sleeping endoscope * A person who refuses to provide consent * SBP \< 80mmHg or SpO2 \< 90% * Patients with adrenocortical dysfunction, chronic steroid users

What they're measuring

Respiratory adverse event

Timeframe: during gastric endoscopic submucosal dissection

Trial details

NCT IDNCT05407870

SponsorKorea University Anam Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-11-24

View on ClinicalTrials.gov More Sedation Complication trials